The Harvard School of Public Health Neuroepidemiology Research Group is a team of scientists collaborating in the epidemiological investigation of multiple sclerosis (MS), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and other neurological diseases. We are based at HSPH, with collaborators at the Massachusetts General Hospital, Brigham and Women’s Hospital, and other institutions both in the U.S. and abroad.
Our primary research involves the application of epidemiological methods to identify causal risk factors for neurological diseases, and our focus is on the conduction of large prospective investigations into the effects of nutrition, environment, and infectious agents on neurological disease risk, as well as the identification of biomarkers and genetic determinants of neurological disease susceptibility. We have been actively working in these areas since 1997, when the National Institute of Neurological Diseases and Stroke funded the documentation of MS and PD among participants in the Nurses’ Health Studies and the Health Professionals Follow-up Study.
Our research has now been extended to multiple additional cohorts, both nationally and internationally. Collectively, these studies constitute a unique resource comprising millions of individuals that we hope will contribute to the discovery of new approaches to the prevention and treatment of these neurological diseases.
Neuroepidemiology Research Group
Harvard School of Public Health
Department of Nutrition